FRANCES ROSARIO: Open Payments
NPI 1679956643 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 16 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $59 · 2025 $315
Food & beverage: $315
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $78 |
| Novo Nordisk Inc | 2 | $32 |
| Astellas Pharma US Inc | 1 | $31 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $24 |
| Boston Scientific Corporation | 1 | $21 |
| PFIZER INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: CAPLYTA, Veozah, Jornay PM, FREESTYLE LIBRE 3, WATCHMAN FLX, Rybelsus, ELIQUIS, MOUNJARO.
Industry payments across NY — which companies pay providers there.
